-
Integration of Bulk and Single-Cell Transcriptomics Reveals BCL2L14 as a Novel IGKC+ T Cell-Associated Therapeutic Target in Breast Cancer
04 Jun 2025 18:48 GMT
… breast cancer (ER+ or PR+), HER2-positive breast cancer (HER2+), and triple-negative breast cancer … pathways activated within breast tumor tissues, potentially … breast cancer (TNBC) cells, and promotes taxol … of triple-negative breast cancers: subtypes and …
-
What I Would Tell the Woman I Was Before Breast Cancer
26 May 2025 19:51 GMT
… At 39 years old, a breast cancer felt like a nuclear bomb … a sense of certainty. My breast cancer diagnosis ripped the illusion of … had no idea that a breast cancer gene, PALB2, lurked in … clinical trial, along with weekly Taxol infusions, left my tumor …
-
Zanidatamab Plus Chemotherapy Shows Promising Anti-Tumor Activity in Treatment of HER2-Mutated Breast Cancer
21 May 2025 23:08 GMT
… (HER2)-mutated metastatic breast cancer (mBC). The data … for Medical Oncology Breast Cancer 2025 Annual Meeting … with chemotherapy (paclitaxel [Taxol; Bristol Myers Squibb], capecitabine … with HER2-mutated metastatic breast cancer, particularly those who …
-
Neoadjuvant Trastuzumab Deruxtecan Improves Pathologic Complete Response in Patients With HER2+ Early Breast Cancer
08 May 2025 16:46 GMT
… AstraZeneca) followed by paclitaxel (Taxol; Bristol Myers Squibb), trastuzumab … (HER2+) early-stage breast cancer (eBC). The data … patients with HER2+ metastatic breast cancer. Pharmacy Times. April … patients-with-her2-metastatic-breast-cancer
3. ENHERTU® …
-
Enhertu Regimen Improves Responses in High-Risk HER2+ Breast Cancer
07 May 2025 17:50 GMT
… -trastuzumab deruxtecan-nxki) followed by Taxol (paclitaxel), Herceptin (trastuzumab) and … in early-stage HER2-positive breast cancer,” Susan Galbraith, executive vice … low, and HER2-ultralow metastatic breast cancer with Enhertu, exploring its potential …
-
AstraZeneca & Daiichi Sankyo’s Enhertu Posts Positive Data as First-Line Breast Cancer Therapy
21 Apr 2025 18:11 GMT
… treatment for HER2-positive metastatic breast cancer. The therapy expanded its approved … was compared to the chemotherapy Taxol combined with Perjeta and another … treatment for metastatic HER2-positive breast cancer.
AstraZeneca and Daiichi Sankyo said …
-
Statin Therapy in Early Breast Cancer: The MASTER Trial; A Randomized Phase III, Placebo-Controlled Comparison of Standard (Neo)Adjuvant Therapy Plus Atorvastatin versus Standard (Neo)Adjuvant Therapy Plus Placebo
17 Apr 2025 14:32 GMT
… , TAX, Taxol, DC, Docetaxel … breast tumor recurrence (invasive breast cancer … breast cancer); Death attributable to any cause (including breast cancer, non-breast cancer … , or unknown cause); Contralateral invasive breast cancer …
-
Metastatic HR+ Or HER2− Breast Cancer Market 2025: Growth Forecasts & Development Of Advanced Therapeutical Strategies
26 Mar 2025 17:32 GMT
… types, such as generic Paclitaxel, Taxol, generic Tamoxifen, Nolvadex, and others … #47;report/breast-cancer-drugs-global-market-report
Breast Cancer Diagnostics Global Market … .com/report/breast-cancer-diagnostics-global-market-report
Breast …
-
Evolving Treatments and Advances in HER2-Positive Breast Cancer
20 Mar 2025 21:42 GMT
… Miami Breast Cancer Conference and the Educated Patient Breast Cancer Summit … Breast Cancer
The treatment of metastatic HER2-positive breast cancer … Future of HER2+ Breast Cancer Treatment
Overall, the … first diagnosed, get Taxol with Herceptin and Perjeta …
-
Plant extract replica shows promise against breast cancer
11 Feb 2025 21:19 GMT
… dish.
Another striking example is Taxol, a landmark cancer drug developed … the discovery of the extract, Taxol went into commercial production in … against HER2 positive breast cancer cells and triple-negative breast cancer cells.
The findings …
About
© 1995-2025